Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD)

被引：0
|
作者：
E. Sobanski
D. Sabljic
B. Alm
G. Skopp
N. Kettler
R. Mattern
P. Strohbeck-Kühner
机构：
[1] Central Institute of Mental Health,Department of Psychiatry and Psychotherapy
[2] Ruprechts-Karl-University of Heidelberg,Institutes of Traffic and Legal Medicine
来源：
Journal of Neural Transmission | 2008年 / 115卷
关键词：
Keywords: Driving outcome; attention-deficit/hyperactivity disorder; methylphenidate; adults;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This study assesses driving behaviour and history of driving outcomes through a semi-structured interview in 27 clinically referred German adults with ADHD and 27 age-, gender- and education-matched non-ADHD controls. In nineteen of the ADHD-subjects a test battery of driving-related cognitive measures was performed (ART 2020) and re-assessed after at least six weeks of treatment with methylphenidate (n = 9) or after a six-week medication free period (n = 10).
引用
收藏
页码：347 / 356
页数：9
相关论文
共 50 条
  • [1] Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD)
    Sobanski, E.
    Sabljic, D.
    Alm, B.
    Skopp, G.
    Kettler, N.
    Mattern, R.
    Strohbeck-Kuehner, P.
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (02) : 347 - 356
  • [2] Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD)
    Retz, Wolfgang
    Retz-Junginger, Petra
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2014, 264 : S35 - S43
  • [3] Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD)
    Wolfgang Retz
    Petra Retz-Junginger
    European Archives of Psychiatry and Clinical Neuroscience, 2014, 264 : 35 - 43
  • [4] Effects of methylphenidate on driving ability in adults with attention deficit hyperactivity disorder
    Volkerts, E. R.
    Bekker, E. M.
    De Roos, M.
    Minova, A.
    Eijken, E. J. E.
    Kooij, J. J. S.
    Buitelaar, J. K.
    Kenemans, J. L.
    Verbaten, M. N.
    Olivier, B.
    Verster, J. C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S252 - S252
  • [5] Driving ability in adults with attention-deficit hyperactivity disorder significantly improves when treated with methylphenidate
    Verster, J. C.
    Bekker, E. M.
    De Roos, M.
    Minova, A.
    Eijken, E. J. E.
    Kooij, J. J. S.
    Buitelaar, J. K.
    Kenemans, J. L.
    Verbaten, M. N.
    Olivier, B.
    Volkerts, E. R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S554 - S555
  • [6] Driving impairments in teens and adults with attention-deficit/hyperactivity disorder
    Barkley, RA
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2004, 27 (02) : 233 - +
  • [7] Methylphenidate in adults with attention-deficit/hyperactivity disorder
    Koesters, M.
    Weinmann, S.
    Becker, T.
    NERVENARZT, 2007, 78 (09): : 1065 - 1066
  • [8] OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
    Antoni Ramos-Quiroga, J.
    Corominas, Margarida
    Castells, Xavier
    Bosch, Rosa
    Casas, Miguel
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1121 - 1131
  • [9] Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder
    Olfson, Mark
    Marcus, Steven C.
    Zhang, Huabin F.
    Wan, George J.
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (07): : 570 - 577
  • [10] Impact of methylphenidate treatment on the rate of accidents in adults with Attention Deficit Hyperactivity Disorder (ADHD)
    Marin, M.
    Ponce, G.
    Martinez, I.
    Rubio, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S620 - S621
12345